Xilio Therapeutics Inc
NASDAQ:XLO
Income Statement
Earnings Waterfall
Xilio Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-79.1m
USD
|
Operating Income
|
-79.1m
USD
|
Other Expenses
|
2.7m
USD
|
Net Income
|
-76.4m
USD
|
Income Statement
Xilio Therapeutics Inc
Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||
Operating Expenses |
(55)
|
(63)
|
(75)
|
(76)
|
(75)
|
(80)
|
(81)
|
(86)
|
(89)
|
(91)
|
(87)
|
(84)
|
(79)
|
|
Selling, General & Administrative |
(11)
|
(13)
|
(16)
|
(19)
|
(24)
|
(25)
|
(28)
|
(30)
|
(30)
|
(31)
|
(30)
|
(29)
|
(27)
|
|
Research & Development |
(44)
|
(50)
|
(59)
|
(58)
|
(51)
|
(54)
|
(53)
|
(56)
|
(59)
|
(60)
|
(57)
|
(55)
|
(52)
|
|
Operating Income |
(55)
N/A
|
(63)
-16%
|
(75)
-18%
|
(76)
-2%
|
(75)
+1%
|
(80)
-6%
|
(81)
-2%
|
(86)
-5%
|
(89)
-4%
|
(91)
-3%
|
(87)
+5%
|
(84)
+3%
|
(79)
+6%
|
|
Pre-Tax Income | ||||||||||||||
Interest Income Expense |
(1)
|
0
|
0
|
0
|
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
Total Other Income |
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
1
|
2
|
3
|
4
|
4
|
3
|
|
Pre-Tax Income |
(55)
N/A
|
(64)
-15%
|
(75)
-18%
|
(77)
-2%
|
(76)
+1%
|
(80)
-6%
|
(82)
-2%
|
(85)
-4%
|
(88)
-3%
|
(90)
-1%
|
(84)
+6%
|
(81)
+4%
|
(76)
+6%
|
|
Net Income | ||||||||||||||
Income from Continuing Operations |
(55)
|
(64)
|
(75)
|
(77)
|
(76)
|
(80)
|
(82)
|
(85)
|
(88)
|
(90)
|
(84)
|
(81)
|
(76)
|
|
Net Income (Common) |
(55)
N/A
|
(64)
-15%
|
(75)
-18%
|
(77)
-2%
|
(76)
+1%
|
(80)
-6%
|
(82)
-2%
|
(85)
-4%
|
(88)
-3%
|
(90)
-1%
|
(84)
+6%
|
(81)
+4%
|
(76)
+6%
|
|
EPS (Diluted) |
-2.07
N/A
|
-2.4
-16%
|
-2.84
-18%
|
-2.89
-2%
|
-2.84
+2%
|
-2.94
-4%
|
-2.99
-2%
|
-3.11
-4%
|
-3.22
-4%
|
-3.27
-2%
|
-3.07
+6%
|
-2.96
+4%
|
-2.78
+6%
|